Connect with us

Health

Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma – News-Medical.Net

An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma, according…

Published

on

Article feature image

An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma, according to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center. These results…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending